A detailed history of Covestor LTD transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 24 shares of RVNC stock, worth $61. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 26 7.69%
Holding current value
$61
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$2.57 - $2.57 $5 - $5
-2 Reduced 7.69%
24 $0
Q2 2024

Aug 09, 2024

BUY
$2.34 - $4.73 $37 - $75
16 Added 160.0%
26 $0
Q1 2024

May 10, 2024

SELL
$4.65 - $9.31 $4 - $9
-1 Reduced 9.09%
10 $0
Q4 2023

Feb 09, 2024

BUY
$5.81 - $11.2 $29 - $56
5 Added 83.33%
11 $0
Q3 2023

Nov 13, 2023

SELL
$11.47 - $25.07 $11 - $25
-1 Reduced 14.29%
6 $0
Q2 2023

Aug 11, 2023

SELL
$24.7 - $37.61 $24 - $37
-1 Reduced 12.5%
7 $0
Q4 2022

Feb 13, 2023

SELL
$18.32 - $30.66 $54 - $91
-3 Reduced 27.27%
8 $0
Q3 2022

Nov 14, 2022

SELL
$14.33 - $28.47 $28 - $56
-2 Reduced 15.38%
11 $0
Q2 2022

Aug 10, 2022

SELL
$11.52 - $20.4 $138 - $244
-12 Reduced 48.0%
13 $0
Q1 2022

May 13, 2022

SELL
$12.36 - $20.31 $74 - $121
-6 Reduced 19.35%
25 $0
Q4 2021

Feb 10, 2022

BUY
$12.46 - $27.87 $386 - $863
31 New
31 $1,000

Others Institutions Holding RVNC

About Revance Therapeutics, Inc.


  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.